AZD8566 Food Effect/Microtracer Study
Study identifier:D1320C00011
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An Open, randomised, Phase I, 2-Period Crossover Trial to Investigate the Absolute Bioavailability and the Effect of Food on the Oral Bioavailability of AZD8566 in Healthy Volunteers
Medical condition
Healthy Volunteer Study
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD8566, AZD8566 IV carbon labelled
Sex
All
Actual Enrollment
21
Study type
Interventional
Age
18 Years - 55 Years
Date
Study Start Date: 01 Mar 2009
Primary Completion Date: 01 Mar 2009
Study Completion Date: 01 Apr 2009
Study design
Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Jo Collier
Pharmaceutical Profiles, Mere Way, Ruddington Fields, Nottingham NG11 6JS
